INGALLS & SNYDER LLC CORT — CORCEPT THERAPEUTICS COMMON

Ownership history in INGALLS & SNYDER LLC  ·  76 quarters on record

AI Ownership Summary

INGALLS & SNYDER LLC reported CORCEPT THERAPEUTICS COMMON (CORT) in 76 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 29.09% in 2025 Q1. The latest visible filing shows CORT at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CORT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was INGALLS & SNYDER LLC's position in CORCEPT THERAPEUTICS COMMON, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CORT was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
29.09% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CORT stock page INGALLS & SNYDER LLC fund profile INGALLS & SNYDER LLC full holdings
How INGALLS & SNYDER LLC held CORT — position size vs. price
% of Fund (quarterly)    CORT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 18 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 3,200 -7,605,516 -100.0% 0.00% $129 2026-05-13 $57.08
2026 Q1 ADDED — — — 7,608,716 +7,605,516 +237672.4% 10.86% $307K 2026-05-13 $57.08
2025 Q4 REDUCED 100.0% +15.8% ❌ 3,200 -7,191,860 -100.0% 0.00% $111K 2026-02-13 $39.97
2025 Q4 ADDED — — — 7,195,060 +7,194,360 +1027765.7% 9.19% $250.4M 2026-02-13 $39.97
2025 Q3 REDUCED 100.0% -4.0% ✅ 700 -7,697,284 -100.0% 0.00% $58K 2025-11-07 $73.72
2025 Q3 REDUCED — — — 7,697,984 -24,938 -0.3% 20.92% $639.8M 2025-11-07 $73.72
2025 Q2 ADDED — — — 7,722,922 +7,711,922 +70108.4% 20.11% $566.9M 2025-07-31 $67.17
2025 Q1 REDUCED 99.9% -35.7% ✅ 11,000 -7,731,584 -99.9% 0.04% $1.3M 2025-05-12 $72.14
2025 Q1 ADDED — — — 7,742,584 +7,731,584 +70287.1% 29.09% $884.4M 2025-05-12 $72.14
2024 Q4 REDUCED 99.9% +126.7% ❌ 11,000 -8,088,747 -99.9% 0.02% $554K 2025-01-29 $61.53
2024 Q4 ADDED — — — 8,099,747 +8,088,247 +70332.6% 16.01% $408.1M 2025-01-29 $61.53
2024 Q3 REDUCED 99.9% +9.9% ❌ 11,500 -8,255,256 -99.9% 0.02% $532K 2024-11-14 $54.79
2024 Q3 ADDED — — — 8,266,756 +28,650 +0.3% 14.93% $382.6M 2024-11-14 $54.79
2024 Q2 ADDED — — — 8,238,106 +8,230,106 +102876.3% 11.51% $267.7M 2024-07-31 $38.67
2024 Q2 ADDED — — — 8,000 +6,500 +433.3% 0.01% $260K 2024-07-31 $38.67
2024 Q1 REDUCED 100.0% +29.7% ❌ 1,500 -8,301,647 -100.0% 0.00% $38K 2024-05-13 $27.53
2024 Q1 REDUCED — — — 8,303,147 -48,680 -0.6% 9.24% $209.2M 2024-05-13 $27.53
2023 Q4 ADDED — — — 8,351,827 +11,634 +0.1% 12.26% $271.3M 2024-01-29 $22.33
58 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CORT

As of 2026 Q1 — sorted by position size

Sio Capital Management, LLC 3Y 7Y 3.9% Propel Bio Management, LLC 3.8% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 3.07% MPM BioImpact LLC 3Y 3.07% Parallel Advisors, LLC 3Y 7Y 2.88% Boxer Capital Management, LLC 1.32% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 1.1% DIADEMA PARTNERS LP 1.09% Birchview Capital, LP 3Y 7Y 1.08% S&T BANK/PA 3Y 7Y 1.02%

FAQ About INGALLS & SNYDER LLC and CORT

These are the practical questions this page is built to answer before you even open the full history table.

How long has INGALLS & SNYDER LLC reported owning CORT?

INGALLS & SNYDER LLC reported CORT across 18 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CORT position in INGALLS & SNYDER LLC's portfolio?

The largest reported portfolio weight for CORT was 29.09% in 2025 Q1.

What is the latest reported CORT position on this page?

The most recent filing on this page is 2026 Q1, when INGALLS & SNYDER LLC reported 3,200 shares, equal to 0.00% of portfolio, with an estimated market value of $129.

What does the chart on this CORT ownership page compare?

The chart compares INGALLS & SNYDER LLC's quarterly CORT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did INGALLS & SNYDER LLC time their CORT position?

Based on 13F filing dates vs. subsequent CORT price moves, INGALLS & SNYDER LLC correctly timed 36 out of 72 reported position changes (50%). The annualised alpha on CORT relative to SPY over the holding period was +5.4%.

← Back to INGALLS & SNYDER LLC Holdings